Charles Schwab Investment Management Inc Kezar Life Sciences, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 63,358 shares of KZR stock, worth $412,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,358

Previous 63,358 -0.0%

Holding current value

$412,460

Previous $38,000 26.32%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$0.6 - $0.92 $97,879 - $150,081	-163,132 Reduced 72.03%	63,358 $38,000
Q4 2023 Feb 06, 2024	SELL	$0.72 - $1.15 $85,644 - $136,792	-118,950 Reduced 34.43%	226,490 $215,000
Q3 2023 Nov 08, 2023	BUY	$1.08 - $2.54 $172,336 - $405,310	159,571 Added 85.85%	345,440 $411,000
Q2 2023 Aug 09, 2023	BUY	$2.31 - $3.06 $100,621 - $133,290	43,559 Added 30.61%	185,869 $455,000
Q1 2023 May 11, 2023	BUY	$3.13 - $7.31 $6,767 - $15,804	2,162 Added 1.54%	142,310 $445,000
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $10,275 - $14,150	1,608 Added 1.16%	140,148 $986,000
Q3 2022 Nov 14, 2022	BUY	$7.99 - $10.75 $157,011 - $211,248	19,651 Added 16.53%	138,540 $1.19 Million
Q2 2022 Aug 15, 2022	BUY	$4.58 - $17.13 $81,395 - $304,434	17,772 Added 17.58%	118,889 $984,000
Q1 2022 May 13, 2022	BUY	$12.3 - $18.33 $144,082 - $214,717	11,714 Added 13.1%	101,117 $1.68 Million
Q4 2021 Feb 11, 2022	BUY	$7.44 - $16.72 $31,932 - $71,762	4,292 Added 5.04%	89,403 $1.5 Million
Q3 2021 Nov 16, 2021	SELL	$4.85 - $9.73 $23,765 - $47,677	-4,900 Reduced 5.44%	85,111 $736,000
Q2 2021 Aug 16, 2021	BUY	$4.93 - $6.46 $67,516 - $88,469	13,695 Added 17.95%	90,011 $489,000
Q1 2021 May 17, 2021	BUY	$5.24 - $6.99 $1,666 - $2,222	318 Added 0.42%	76,316 $455,000
Q3 2020 Nov 13, 2020	BUY	$4.36 - $5.5 $40,216 - $50,732	9,224 Added 13.81%	75,998 $368,000
Q2 2020 Aug 14, 2020	SELL	$3.6 - $7.75 $36,309 - $78,166	-10,086 Reduced 13.12%	66,774 $346,000
Q1 2020 May 15, 2020	BUY	$2.77 - $5.75 $115,794 - $240,367	41,803 Added 119.24%	76,860 $336,000
Q2 2019 Aug 09, 2019	BUY	$7.09 - $21.9 $48,594 - $150,102	6,854 Added 24.3%	35,057 $271,000
Q1 2019 May 14, 2019	BUY	$16.83 - $23.75 $264,449 - $373,183	15,713 Added 125.8%	28,203 $501,000
Q4 2018 Feb 14, 2019	BUY	$20.21 - $32.9 $54,971 - $89,488	2,720 Added 27.84%	12,490 $295,000
Q3 2018 Nov 13, 2018	BUY	$15.5 - $21.41 $151,435 - $209,175	9,770 New	9,770 $210,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $445M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Kezar Life Sciences, Inc. Transaction History